hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway
The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
hTERT is the catalytic subunit of the telomerase and is hence required for telomerase maintenance activity and cancer cell immortalization. Here, we show that acute hTERT depletion has no adverse effects on the viability or proliferation of cervical and colon carcinoma cell lines, as evaluated within 72 h after transfection with hTERT-specific small interfering RNAs (siRNAs). Within the same time frame, hTERT depletion facilitated the induction of apoptotic cell death by cisplatin, etoposide, mitomycin C and reactive oxygen species, yet failed to sensitize cells to death induction via the CD95 death receptor. Experiments performed with p53 knockout cells or chemical p53 inhibitors revealed that p53 was not involved in the chemosensitizing effect of hTERT knockdown. However, the proapoptotic Bcl-2 family protein Bax was involved in cell death induction by hTERT siRNAs. Depletion of hTERT facilitated the conformational activation of Bax induced by genotoxic agents. Moreover, Bax knockout abolished the chemosensitizing effect of hTERT siRNAs. Inhibition of mitochondrial membrane permeabilization by overexpression of Bcl-2 or expression of the cytomegalovirus-encoded protein vMIA (viral mitochondrial inhibitor of apoptosis), which acts as a specific Bax inhibitor, prevented the induction of cell death by the combination of hTERT depletion and chemotherapeutic agents. Altogether, our data indicate that hTERT inhibition may constitute a promising strategy for facilitating the induction of the mitochondrial pathway of apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, hTERT protein acts on mitochondria to inhibit the intrinsic pathway of apoptosis, 129”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [129]
In the citing paper
“and interacts with chromatin remodeling factors (such as SMARCA4) and transcription factors (such as NF-kB) to transactivate genes involved in tumor progression.129”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [129]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“…inactivate the p53 pathway that links the DNA-damage response to mitochondrial apoptosis, either through transcriptional effects of p53 or owing to a physical interaction of p53 with proapoptotic members of the Bcl-2 family (Vogelstein et al., 2000; Vousden and Lu, 2002; Perfettini et al., 2004).”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Self-citationLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Switching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Movement of Bax from the Cytosol to Mitochondria during Apoptosis
Wolter, K. G., Hsu, Y.-T., Smith, C. L., Nechushtan, A., Xi, X.-G., & Youle, R. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1281 · Cited by 1,806
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1661 · Cited by 1,166
Self-citation
Cited by
Items 101–147 of 147
Role of Senescence and Neuroprotective Effects of Telomerase in Neurodegenerative Diseases
Ding, X., Liu, X., Wang, F., Wang, F., & Geng, X. (2019) · Rejuvenation Research · doi:10.1089/rej.2018.2115 · Cited by 12
Yu, M., Kong, H., Zhao, Y., Sun, X., Zheng, Z., Yang, C., & Zhu, Y. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.21998 · Cited by 12
Cheng, G., Yuan, X., Wang, F., Sun, Q., Xin, Q., Li, K., Sun, C., Lin, Z., Luan, Y., Xu, Y., et al. (2017) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2017.9 · Cited by 10
Song, M.-S., Jeong, J., Cho, K.-S., & Lee, S. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.79 · Cited by 10
Telomere length in normal and neoplastic canine tissues
Cadile, C. D., Kitchell, B. E., Newman, R. G., Biller, B. J., & Hetler, E. R. (2007) · American Journal of Veterinary Research · doi:10.2460/ajvr.68.12.1386 · Cited by 12
Shi, Y., Cui, Y., Wu, H., Zhang, W., Zhao, C., Liu, H., Lan-qin, G., Wu, B., Ai-zhen, Y. U., & ZHANG, Y.-Y. (2012) · 中医杂志:英文版 · doi:10.1016/s0254-6272(12)60030-2 · Cited by 9
Li, H., & Wei, C. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.085 · Cited by 7
Wang, J., Zhang, M. Y., Xu, S., Cheng, J., Yu, Z., & Hu, X. (2018) · Biotechnic & Histochemistry · doi:10.1080/10520295.2018.1471523 · Cited by 7
Accumulation of TERT in mitochondria exerts two opposing effects on apoptosis
Ebata, H., Shima, T., Iizuka, R., & Uemura, S. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13682 · Cited by 7
Li, H., Wang, Q., Li, D., Wang, Q., & Wu, H. (2014) · Oncology Reports · doi:10.3892/or.2014.3697 · Cited by 6
Potential roles of telomeres and telomerase in neurodegenerative diseases
Shao, J., Wang, J., Li, B., & Liu, C. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.41 · Cited by 6
Palamarchuk, A. I., Kovalenko, E. I., & Streltsova, M. A. (2024) · Biomedicines · doi:10.3390/biomedicines12030650 · Cited by 5
Lepreux, S., Doudnikoff, É., Aubert, I., Bioulac‐Sage, P., Bloch, B., & Martin‐Négrier, M. (2008) · Ultrastructural Pathology · doi:10.1080/01913120802034504 · Cited by 5
Inhibition of Human Tumor Cell Proliferation by the Telomerase Inhibitor TELIN
Kakiuchi, Y., Oyama, M., Nakatake, M., Okamoto, Y., Kai, H., Arima, H., Murofushi, H., & Murakami‐Murofushi, K. (2010) · CYTOLOGIA · doi:10.1508/cytologia.75.177 · Cited by 5
Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells
Vania, L., Morris, G., Ferreira, E., & Weiss, S. F. T. (2021) · BMC Cancer · doi:10.1186/s12885-021-08081-3 · Cited by 4
Tomlinson, C. G., Cohen, S. B., & Bryan, T. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00017-6 · Cited by 4
Extra-Telomeric Roles of Telomeric Proteins
Ghosh, A., & Tergaonkar, V. (2012) · InTech eBooks · doi:10.5772/38661 · Cited by 3
Iannilli, F., Zalfa, F., Gärtner, A., Bagni, C., & Dotti, C. G. (2013) · PLoS ONE · doi:10.1371/annotation/e2d5d0e4-fb3a-4d53-a2de-99cd8d045d1c · Cited by 4
Tichon, A., Erez, E., Tsory, S., Beit-Yanai, E., & Priel, E. (2023) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001085 · Cited by 2
Current Endeavors for Enhancing Efficacy of Paclitaxel for Treatment of Glioblastoma
Karmakar, S., Banik, N. L., & Ray, S. K. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0410-2_15 · Cited by 2
Extra-Telomeric Effects of Telomerase (hTERT) in Cell Death
Bellot, G. L., & Wang, Y. (2013) · InTech eBooks · doi:10.5772/48583 · Cited by 2
Biyolojik Yaşlanma Teorileri: Oksidatif Stresin Rolü
Karasu, Ç. (2008) · Turkiye Klinikleri Tip Bilimleri Dergisi · Cited by 2
Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma
Bae, J.-H., & Park, J. S. (2007) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.1.3.305 · Cited by 1
Khattar, E., & Tergaonkar, V. (2016) · InTech eBooks · doi:10.5772/62130 · Cited by 1
Cell Culture Bioprocess Technology: Biologics and Beyond
O’Brien, S. A., Park, Y., Azarin, S. M., & Hu, W. (2018) · Learning materials in biosciences · doi:10.1007/978-3-319-74854-2_1 · Cited by 1
Control of gene expression in prostate epithelial cell differentiation hierarchy
Rane, J. K. (2012) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Investigation of the leukaemic activity of MLL-fusionsin human haematopoietic cells
Osaki, H. (2011) · UCL Discovery (University College London) · Cited by 1
MULTIFACTORIAL MODULATION OF THE BLOOD-BRAIN BARRIER: RELATIONSHIP TO STROKE
Zhang, B. (2013) · UKnowledge (University of Kentucky)
Downregulation of Telomerase in CoCl2-Induced Apoptosis of Myeloid Leukemic Cells
Xu, Y.-B., Zhang, J., Bendirdjian, E. S., Wu, Y., & Chen, G. (2008) · The Open Hematology Journal · doi:10.2174/1874276900802010074
The primary cilium as a regulator of cellular senescence in human fibroblasts
Breslin, L. (2014) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17764
Lysko, M. D. (2016) · TSpace (University of Toronto)
Telomeres, telomerase, oncogenesis and measure of health
Yegorov, Y. E. (2010) · Clinical oncohematology · Cited by 2
Off‐Telomere Functions of Telomerase
Masutomi, K., & Hahn, W. C. (2012) · Wiley eBooks · doi:10.1002/9781118268667.ch8
Singh, O. (2017) · Scholarship@Western (Western University)
Chemical and Pharmacological Modulation of Telomerase
Soares, J. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/fgzz-7e09
Acción biológica de la inmunofilina de alto peso molecular FKBP51 en procesos malignos
Zgajnar, N. R. (2017) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Rouge, T. D. L. M., Galluzzi, L., Olaussen, K. A., Zermati, Y., Tasdemir, E., Robert, T., Ripoche, H., Lazar, V., Dessen, P., Harper, F., et al. (2023) · doi:10.1158/0008-5472.22368087
Self-citationMomtareen, T. (2025) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.13031
Télomerase et destin des tumeurs neuroblastiques
Samy, M. (2010) · theses.fr (ABES) · doi:10.70675/07050b7dz1056z4e65za6f1z34cea95a398b · Cited by 2
Huang, F., Rusbuldt, J. J., Luistro, L. L., Colton, H. M., & Eid, J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197399
The Role of Telomerase in Cellular Stress Response—Therapeutic Potential of Telomerase Inhibitors
Pawlak, S., Kostrzewa, M., Lisiak, N., & Rubiś, B. (2026) · Biomedicines · doi:10.3390/biomedicines14102171
Rodriguez-Vidal, J. F., Alcaraz‐Pérez, F., Bernal-Bermúdez, B., García‐Moreno, D., Ayala, A. G., Cabas, I., Mulero, V., & Cayuela, M. L. (2026) · Research Square · doi:10.21203/rs.3.rs-11107439/v1
Senescence Signatures of Human Hematopoietic Stem Cells
Zimmermann, S., & Martens, U. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_7
The role of the cell attachment in the regulation of telomerase during keratinocyte differentiation
Cereser, B. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
Metadata
- Authors
- Massard, C., Zermati, Y., Pauleau, A.-L., Larochette, N., Métivier, D., Sabatier, L., Kroemer, G., & Soria, J.-C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Corresponding author
- Kroemer, G
- Soria, J-C
- Venue
- Oncogene
- Published
- 2006-04-17
- Volume
- 25
- Issue
- 33
- Pages
- 4505-4514
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1486872926
- Cited by
- 144
- References
- 57
- Citations by year
- 2026: 3 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 12 · 2013: 17 · 2012: 11
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-01-24)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Ligue Contre le Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- hTERT, telomerase, mitochondrial apoptosis, Bax, Bcl-2 family proteins, p53, chemosensitization, reactive oxygen species, mitochondrial membrane permeabilization, cervical cancer, colon cancer, siRNA knockdown
- MeSH terms
- Antineoplastic Agents, Cell Survival, Uterine Cervical Neoplasms, Cisplatin, Colonic Neoplasms, DNA-Binding Proteins, Etoposide, Female, Humans, Mitochondria, Mitomycin, Apoptosis, Reactive Oxygen Species, fas Receptor, Telomerase, Catalytic Domain, Cell Line, Tumor, bcl-2-Associated X Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.